Safe and Effective Weight Loss. Contact Us Today for a Free Consultation.

​Lose weight and improve your health with a personalized weight loss plan supervised by a medical physician and powered by the most effective weight loss medications on the market.

Momenta Weight Loss Program

Losing weight is a challenge. There are new medications that are available to help with weight loss.  You may know them as Ozempic, Rybelsus or Wegovy.  Stronger medications include Zepbound or Mounjaro.  All these medications are called Peptides. It’s a simple, small injection once a week.  Weight loss of up to 18% has been achieved with most patients.

These Peptides are FDA approved for weight loss, Type 2 diabetes and heart disease. Weight loss medications can help you make permanent changes and assist you in attaining your goals. Let us help you!

Registered and FDA-approved for Weight Loss, Diabetes, and Heart Disease:

  • Ozempic
  • Wegovy
  • Rybelsus
  • Mounjaro
  • Zepbound

Expertly compounded to contribute to weight loss of up to 17-20 % of your body weight.

Benefits of Our Weight Loss Solutions

Safe and Effective


We offer well-studied medications with proven safety profiles.

Effective for Long-Term Weight Loss


These treatments have been shown to help people maintain their weight loss over the long term.

Improves Overall Health:


Semaglutide/Tirzepatide may help to improve blood pressure, cholesterol levels, and blood sugar control.

Schedule a Consultation Today and Start Your Journey to a Healthier You!

If you are interested in learning more about our medical physician supervised weight loss program, please complete this form and schedule a consultation today. We would be happy to answer your questions and help you determine if our program is right for you.

Requirements: Individuals with a Body Mass Index over 30.

Request a Consultation

Complete the form below to be contacted by a team member and to receive more information.

"*" indicates required fields

May We Text You?*
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

Medical Literature References

Semaglutide and cardiovascular disease: Semaglutide has been shown to reduce the risk of cardiovascular events in people with obesity and type 2 diabetes. (Finer, 2022)

Semaglutide and blood pressure: Semaglutide has been shown to lower blood pressure in people with obesity and hypertension. (Rosenstock, 2022)

Semaglutide and cholesterol: Semaglutide has been shown to improve cholesterol levels in people with obesity and high cholesterol. (Garvey, 2022)

Semaglutide and blood sugar control: Semaglutide has been shown to improve blood sugar control in people with type 2 diabetes. (Herman, 2022)